Researchers continue to excited about this new drug, a innovative dual treatment showing remarkable results in clinical trials for weight reduction . It acts by targeting several pathways : GLP-1 and GIP, https://deaconzkhv176781.pointblog.net/a-new-prospect-for-weight-reduction-92132596